Patent details

EP4467200 Title: EZH2 INHIBITION THERAPIES FOR THE TREATMENT OF ANDROGEN RECEPTOR MUTATED PROSTATE CANCERS

Basic Information

Publication number:
EP4467200
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP242062651
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
EZH2 INHIBITION THERAPIES FOR THE TREATMENT OF ANDROGEN RECEPTOR MUTATED PROSTATE CANCERS
French Title of Invention:
THÉRAPIES D'INHIBITION D'EZH2 POUR LE TRAITEMENT DE CANCERS DE LA PROSTATE AYANT SUBI UNE MUTATION DU RÉCEPTEUR DES ANDROGÈNES
German Title of Invention:
EZH2-HEMMUNGSTHERAPIEN ZUR BEHANDLUNG VON DURCH DEN ANDROGENREZEPTOR MUTIERTEN PROSTATAKREBSEN
SPC Number:

Dates

Filing date:
18/11/2021
Grant date:
27/05/2026
EP Publication Date:
27/11/2024
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/05/2026
EP B1 Publication Date:
27/05/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/11/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/05/2026
 
 

Name:
Constellation Pharmaceuticals, Inc.
Address:
470 Atlantic Avenue, Suite 1401, Boston, MA 02210 US, United States (US)

Inventor

1

Name:
WU,, Rentian
Address:
United States (US)

2

Name:
BRADLEY,, William D.
Address:
United States (US)

3

Name:
TROJER,, Patrick
Address:
United States (US)

4

Name:
CUI,, Jike
Address:
United States (US)

5

Name:
SUN,, Kaiming
Address:
United States (US)

6

Name:
WANG,, Jing
Address:
United States (US)

Priority

Priority Number:
202063115165 P
Priority Date:
18/11/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4433; A61K 31/4166; A61K 45/06; A61P 35/00; A61P 35/04;

Publication

European Patent Bulletin

Issue number:
202622
Publication date:
27/05/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages